Sernova Corp T.SVA

Alternate Symbol(s): SEOVF

Healthcare Biotechnology

Sernova Corp. is a Canada-based clinical-stage biotechnology company, which is developing therapeutic cell technologies for chronic diseases, including insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. The Company is focused on developing a functional cure for insulin-dependent diabetes with its therapeutic cell technology, the Cell Pouch System, a novel implantable and scalable medical device with immune protected therapeutic cells. The Cell Pouch is a scalable, implantable medical device. The Cell Pouch is designed to create a vascularized organ-like environment for the transplantation and engraftment of therapeutic cells. Its regenerative medicine therapeutic approach is to provide cell therapies where the cells, transplanted within an organ-like vascularized implantable device, the Cell Pouch, generates proteins, hormones or factors released into the bloodstream for treatment of diseases requiring replacement of these molecules in the body.

TSX:SVA - Post by User

Sernova Corp > Dr. Anke M. Schulte

<< Previous

Bullboard Posts

Next >>

Comment by BioTeckon Jul 18, 2021 11:54pm

151 Views

Post# 33567693

RE:RE:Dr. Anke M. Schulte

She left Sanofi a long time ago. You are surprised that someone with her background got a job with another big pharma company? Where did you expect her to go? McDonalds? Keep reaching folks, but make sure you stretch before you reach that far.

<< Previous

Bullboard Posts

Next >>

Investors eye Australian gold mining projects amid promising developments